We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Lauren
Heathcote
Lauren.heathcote@kcl.ac.uk
Emily
Dowling
Emily.j.dowling@kcl.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Malignant neoplasms of bone and articular cartilageMalignant neoplasms of eye, brain and other parts of central nervous systemMalignant neoplasms of ill-defined, secondary and unspecified sitesMalignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Survivors of childhood cancer experience impaired health-related quality of life, psychological distress, and pain. A previously developed body mindset intervention has improved health-related quality of life and symptom distress in adult cancer patients. In the current research, we will examine whether a body mindset intervention can instil adaptive body mindsets, boost resilience, and improve physical and psychological functioning in survivors of childhood cancer.
Survivors of childhood cancer will be randomised to the body mindset intervention or an active attention control group. The body mindset intervention aims to instil adaptive mindsets that the child’s body is resilient, working with them rather than against them, and is capable of healing after cancer treatment and that an experience of cancer can be an opportunity. Participants receiving the body mindset intervention will complete three modules over six-weeks consisting of short films and reflection exercises to guide participants to more adaptive body mindsets. Participants in this group will also complete a range of questionnaires at baseline, weeks two, four, and six, and at a 10-week and 3-month follow-up.
Participants in the active attention control group complete the same questionnaires at baseline, weeks two, four, and six, and at a 10-week and 3-month follow-up. Therefore, the purpose of the active attention control group is to control for completing online surveys and engaging with the research team to receive surveys.
Survivors of childhood cancer aged 16-25 will be recruited from The Royal Marsden Hospital, University College London Hospital (UCLH), and University Hospital Southampton (UHS). Clinicians at the hospitals will screen medical records and contact those who are eligible to provide information about the study. Overall, we predict that the body mindset intervention will increase adaptive body mindsets, reduce maladaptive body mindsets, and improve health-related quality of life, resilience, psychological and physical functioning compared to the active attention control group.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Psychological & Behavioural;
You can take part if:
You may not be able to take part if:
Participants will be excluded if they have significant cognitive impairment that would precede engagement with the digital intervention or completion of self-report questionnaires. This information will be self-reported by the patient, caregiver or clinical team member.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Lauren
Heathcote
Lauren.heathcote@kcl.ac.uk
Emily
Dowling
Emily.j.dowling@kcl.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by King's College London and funded by MEDICAL RESEARCH FOUNDATION .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 59180
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
